Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

The adaptor protein FHL2 enhances the cellular innate immune response to influenza A virus infection.

Nordhoff C, Hillesheim A, Walter BM, Haasbach E, Planz O, Ehrhardt C, Ludwig S, Wixler V.

Cell Microbiol. 2012 Jul;14(7):1135-47. doi: 10.1111/j.1462-5822.2012.01787.x. Epub 2012 Apr 12.

PMID:
22417706
2.

FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.

Hamidouche Z, Haÿ E, Vaudin P, Charbord P, Schüle R, Marie PJ, Fromigué O.

FASEB J. 2008 Nov;22(11):3813-22. doi: 10.1096/fj.08-106302. Epub 2008 Jul 24.

PMID:
18653765
3.
4.

Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells.

Le Goffic R, Bouguyon E, Chevalier C, Vidic J, Da Costa B, Leymarie O, Bourdieu C, Decamps L, Dhorne-Pollet S, Delmas B.

J Immunol. 2010 Oct 15;185(8):4812-23. doi: 10.4049/jimmunol.0903952. Epub 2010 Sep 15.

5.
6.

Activation of the coactivator four-and-a-half-LIM-only protein FHL2 and the c-fos promoter through inhibition of protein phosphatase 2A.

Johannessen M, Olsen PA, Johansen B, Seternes OM, Moens U.

Biochem Pharmacol. 2003 Apr 15;65(8):1317-28.

PMID:
12694872
7.

Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus.

Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M.

J Biol Chem. 2005 Feb 18;280(7):5571-80. Epub 2004 Dec 3.

8.

The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.

Nouët Y, Dahan J, Labalette C, Levillayer F, Julien B, Jouvion G, Cairo S, Vives FL, Ribeiro A, Huerre M, Colnot S, Perret C, Nhieu JT, Tordjmann T, Buendia MA, Wei Y.

J Hepatol. 2012 Nov;57(5):1029-36. doi: 10.1016/j.jhep.2012.06.035. Epub 2012 Jul 11.

PMID:
22796152
9.

FHL2: a scaffold protein of carcinogenesis, tumour-stroma interactions and treatment response.

Verset L, Feys L, Trépant AL, De Wever O, Demetter P.

Histol Histopathol. 2016 May;31(5):469-78. doi: 10.14670/HH-11-709. Epub 2015 Dec 17. Review.

PMID:
26676939
10.

The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.

Donelan NR, Dauber B, Wang X, Basler CF, Wolff T, García-Sastre A.

J Virol. 2004 Nov;78(21):11574-82.

11.

Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression.

Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melén K, Matikainen S.

Cytokine Growth Factor Rev. 2001 Jun-Sep;12(2-3):171-80. Review.

PMID:
11325600
12.

The Four-and-a-Half LIM Domain Protein 2 Supports Influenza A Virus-Induced Lung Inflammation by Restricting the Host Adaptive Immune Response.

Masemann D, Leite Dantas R, Sitnik S, Schied T, Nordhoff C, Ludwig S, Wixler V.

Am J Pathol. 2018 May;188(5):1236-1245. doi: 10.1016/j.ajpath.2018.02.004. Epub 2018 Feb 17.

PMID:
29458009
13.

FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer.

Gullotti L, Czerwitzki J, Kirfel J, Propping P, Rahner N, Steinke V, Kahl P, Engel C, Schüle R, Buettner R, Friedrichs N.

Lab Invest. 2011 Dec;91(12):1695-705. doi: 10.1038/labinvest.2011.109. Epub 2011 Aug 8.

14.

FHL2 binds calcineurin and represses pathological cardiac growth.

Hojayev B, Rothermel BA, Gillette TG, Hill JA.

Mol Cell Biol. 2012 Oct;32(19):4025-34. doi: 10.1128/MCB.05948-11. Epub 2012 Jul 30.

16.

FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.

Chen YH, Wu ZQ, Zhao YL, Si YL, Guo MZ, Han WD.

Chin Med J (Engl). 2012 Jul;125(13):2329-33.

PMID:
22882857
17.

The LIM-Only Protein Four and a Half LIM Domain Protein 2 Attenuates Development of Psoriatic Arthritis by Blocking Adam17-Mediated Tumor Necrosis Factor Release.

Leite Dantas R, Brachvogel B, Schied T, Bergmeier V, Skryabin B, Vogl T, Ludwig S, Wixler V.

Am J Pathol. 2017 Nov;187(11):2388-2398. doi: 10.1016/j.ajpath.2017.07.015. Epub 2017 Aug 18.

PMID:
28823868
18.

Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.

Labalette C, Renard CA, Neuveut C, Buendia MA, Wei Y.

Mol Cell Biol. 2004 Dec;24(24):10689-702.

19.

The biological relevance of FHL2 in tumour cells and its role as a putative cancer target.

Kleiber K, Strebhardt K, Martin BT.

Anticancer Res. 2007 Jan-Feb;27(1A):55-61. Review.

20.

Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.

Lai CF, Bai S, Uthgenannt BA, Halstead LR, McLoughlin P, Schafer BW, Chu PH, Chen J, Otey CA, Cao X, Cheng SL.

J Bone Miner Res. 2006 Jan;21(1):17-28. Epub 2005 Oct 3.

Supplemental Content

Support Center